Isoprostanes, a new group of substances in angiology - Of value in the future?

被引:0
作者
Aghajanian, AA
Oguogho, A
Sinzinger, H
机构
[1] WILHELM AUERSWALD ATHEROSKLEROSEFORSCHUNGSGRP,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,KLIN NUKL MED,A-1090 VIENNA,AUSTRIA
来源
VASA-JOURNAL OF VASCULAR DISEASES | 1997年 / 26卷 / 02期
关键词
atherosclerosis; oxidative stress; prostaglandin; isoprostane;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
F-2-isoprostanes are prostaglandin F-2-like compounds being formed bq non-enzymatic peroxidation of arachidonic acid in vivo. They have a variety of biological actions. The most important compound of this group is 8-epi-PGF(2 alpha) being capable to induce vasoconstriction in particular of lung- and renal vascular tissue. Isoprostanes are present in esterified form; in free form they become available after hydrolysis by phospholipase A. An increase in isoprostanes is an important indicator of oxidative stress in-vivo due to a variety of different noxi such as metal- or nonmetal ions or cigarette smoke. Isoprostanes show an activation of platelets; as a consequence of the interaction of 8-epi-PGF(2 alpha) with specific receptors platelet aggregation may be induced or may be enhanced together with other agonists. Due to these preliminary results isoprostanes could become an interesting substance in angiology in the future for diagnosis of oxidative stress as well as in the understanding of the pathogenesis of atherosclerosis.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
[21]   Is the Future of Statins Aligned with New Novel Lipid Modulation Therapies? [J].
Phan, Binh An P. ;
Toth, Peter P. .
CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (02)
[22]   Surgical Stress and Cancer Progression: New Findings and Future Perspectives [J].
Wang, Yanghanzhao ;
Qu, Mengdi ;
Qiu, Zhiyun ;
Zhu, Shuainan ;
Chen, Wankun ;
Guo, Kefang ;
Miao, Changhong ;
Zhang, Hao .
CURRENT ONCOLOGY REPORTS, 2022, 24 (11) :1501-1511
[23]   Predictive value of coronary calcifications for future cardiac events in asymptomatic patients: underestimation of risk in asymptomatic smokers [J].
Zimmermann, Gregor S. ;
Ruether, Tobias ;
von Ziegler, Franz ;
Greif, Martin ;
Becker, Christoph ;
Becker, Alexander .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2019, 35 (07) :1387-1393
[24]   Diagnostic value of miR-637 in patients with atherosclerosis and its predictive significance for the future cardiovascular events [J].
Xu, Yuxia ;
Zhao, Lixiang ;
Liu, Hai ;
Sun, Bin ;
Zhao, Xinxiang .
VASCULAR, 2021, 29 (05) :704-710
[25]   A Thorough Review on Ethnomedicinal Value of Bioactive Compounds of Pteridophytes against Cancer: Clinical Applications and Future Prospects [J].
Bansal, Priya ;
Kumar, Neeraj ;
Sambhakar, Sharda ;
Kumar, Abhishek ;
Katiyar, Deepti .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
[26]   Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis [J].
Liu, Yuan ;
Jiang, Ping ;
Qu, Yuan ;
Liu, Chuanguo ;
Zhang, Di ;
Xu, Bing ;
Zhang, Qian .
HELIYON, 2024, 10 (06)
[27]   A new perspective on the current and future development potential of ABCG1 [J].
Zeng, Guang-Gui ;
Lei, Qiong ;
Jiang, Wan-Li ;
Zhang, Xing-Xing ;
Nie, Liluo ;
Gong, Xianghao ;
Zheng, Kang .
CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
[28]   High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives [J].
Biscetti, Federico ;
Rando, Maria Margherita ;
Nardella, Elisabetta ;
Cecchini, Andrea Leonardo ;
Pecorini, Giovanni ;
Landolfi, Raffaele ;
Flex, Andrea .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
[29]   Secretory group V phospholipase A2: a new player in thrombosis? [J].
Rao, L. Vijaya Mohan .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) :1918-1920
[30]   Metabolomics analysis provides new insights into the medicinal value of flavonoids in tobacco leaves [J].
Hu, Zuojian ;
Pan, Ziyue ;
Yang, Lujie ;
Wang, Ke ;
Yang, Pengyuan ;
Xu, Zhiqiang ;
Yu, Hongxiu .
MOLECULAR OMICS, 2021, 17 (04) :620-629